BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25106841)

  • 1. Bone mineral density in ambulatory children with epilepsy.
    Yaghini O; Tonekaboni SH; Amir Shahkarami SM; Ahmad Abadi F; Shariat F; Abdollah Gorji F
    Indian J Pediatr; 2015 Mar; 82(3):225-9. PubMed ID: 25106841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The bone mineral content alterations in pediatric patients medicated with levetiracetam, valproic acid, and carbamazepine.
    Serin HM; Koç ZP; Temelli B; Esen İ
    Epilepsy Behav; 2015 Oct; 51():221-4. PubMed ID: 26298867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of antiepileptic drugs on bone density in ambulatory patients.
    Farhat G; Yamout B; Mikati MA; Demirjian S; Sawaya R; El-Hajj Fuleihan G
    Neurology; 2002 May; 58(9):1348-53. PubMed ID: 12011279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiepileptic Drugs and Bone Health in Thai Children with Epilepsy.
    Paticheep S; Chotipanich C; Khusiwilai K; Wichaporn A; Khongsaengdao S
    J Med Assoc Thai; 2015 Jun; 98(6):535-41. PubMed ID: 26219156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of low bone mineral density in children with epilepsy.
    Fong CY; Kong AN; Noordin M; Poh BK; Ong LC; Ng CC
    Eur J Paediatr Neurol; 2018 Jan; 22(1):155-163. PubMed ID: 29122496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy.
    Pack AM; Morrell MJ; Randall A; McMahon DJ; Shane E
    Neurology; 2008 Apr; 70(18):1586-93. PubMed ID: 18443309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone mineral status in ambulatory pediatric patients on long-term anti-epileptic drug therapy.
    Tsukahara H; Kimura K; Todoroki Y; Ohshima Y; Hiraoka M; Shigematsu Y; Tsukahara Y; Miura M; Mayumi M
    Pediatr Int; 2002 Jun; 44(3):247-53. PubMed ID: 11982890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of carbamezapine and valproic acid on bone mineral density, IGF-I and IGFBP-3.
    Kumandas S; Koklu E; Gümüs H; Koklu S; Kurtoglu S; Karakukcu M; Keskin M
    J Pediatr Endocrinol Metab; 2006 Apr; 19(4):529-34. PubMed ID: 16759039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homocysteine and bone loss in epilepsy.
    Elliott JO; Jacobson MP; Haneef Z
    Seizure; 2007 Jan; 16(1):22-34. PubMed ID: 17110134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone mineral metabolism changes in epileptic children receiving valproic acid.
    Oner N; Kaya M; Karasalihoğlu S; Karaca H; Celtik C; Tütüncüler F
    J Paediatr Child Health; 2004 Aug; 40(8):470-3. PubMed ID: 15265190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of bone mineral density in children receiving antiepileptic drugs.
    Akin R; Okutan V; Sarici U; Altunbas A; Gökçay E
    Pediatr Neurol; 1998 Aug; 19(2):129-31. PubMed ID: 9744632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs.
    Välimäki MJ; Tiihonen M; Laitinen K; Tähtelä R; Kärkkäinen M; Lamberg-Allardt C; Mäkelä P; Tunninen R
    J Bone Miner Res; 1994 May; 9(5):631-7. PubMed ID: 8053391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone health and vitamin D status in young epilepsy patients on valproate monotherapy.
    Albaghdadi O; Alhalabi MS; Alourfi Z; Youssef LA
    Clin Neurol Neurosurg; 2016 Jul; 146():52-6. PubMed ID: 27150607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between BsmI polymorphism and bone mineral density in young patients with epilepsy who are taking phenytoin.
    Phabphal K; Geater A; Limapichart K; Sathirapanya P; Setthawatcharawanich S; Witeerungrot N; Thammakumpee N; Leelawattana R
    Epilepsia; 2013 Feb; 54(2):249-55. PubMed ID: 23281616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone density of ambulatory adult patients receiving long-term anticonvulsant drug therapy.
    Ashjazadeh N; Zamani A; Pourjafar M; Omrani GR
    Arch Iran Med; 2009 Nov; 12(6):550-4. PubMed ID: 19877746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of valproate on bone mineral density in adult epileptic patients.
    Boluk A; Guzelipek M; Savli H; Temel I; Ozişik HI; Kaygusuz A
    Pharmacol Res; 2004 Jul; 50(1):93-7. PubMed ID: 15082034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of zonisamide monotherapy on bone health in drug-naive epileptic patients.
    Koo DL; Nam H
    Epilepsia; 2020 Oct; 61(10):2142-2149. PubMed ID: 32944954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bone mineral density in children with long-term antiepileptic therapy].
    Dimić M; Dimić A; Milosević Z; Vojinović J
    Srp Arh Celok Lek; 2013; 141(5-6):329-32. PubMed ID: 23858802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone mineral status in pediatric outpatients on antiepileptic drug monotherapy.
    Tekgul H; Serdaroglu G; Huseyinov A; Gökben S
    J Child Neurol; 2006 May; 21(5):411-4. PubMed ID: 16901447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy.
    Kim SH; Lee JW; Choi KG; Chung HW; Lee HW
    Epilepsy Behav; 2007 Mar; 10(2):291-5. PubMed ID: 17224308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.